Look at CAR-T therapies (your cells are reprogrammed to fight your cancer). Insured patients got access in the US long before, and to a broader degree, than national healthcare systems.

Today, CAR-T utilization in cancers like lymphoma are double those of Europe in many cases. Interestingly the UK is one of the highest in Europe (despite the controversy over cancer drug spending).

While true that the US has uninsured and not all insurance is equal, suffice to say you stand a better chance to get access to new technologies in the US than most countries.

Mounjaro is between 25-50% of the US price in other countries